CGM integration
FreeStyle Libre 3: the application ecosystem and its implications for carb counting
Ecosystem overview
The Abbott FreeStyle Libre 3 sensor reads to the Libre 3 application on the user’s smartphone. From there, three principal data flows matter for carbohydrate-tracking workflows:
- LibreView: Abbott’s clinical export platform. Used predominantly by clinicians for retrospective review. Most carbohydrate-tracking applications do not read directly from LibreView.
- LibreLinkUp: a sharing application that allows family members or care team members to view the user’s glucose data. Not a carbohydrate-tracking integration in itself.
- Apple HealthKit and Google Fit / Health Connect: the platform bridge between the Libre 3 application and other applications.
For a typical carbohydrate-tracking application, the working integration path is the platform bridge: the Libre 3 application writes to HealthKit or Health Connect, and the carbohydrate-tracking application reads the glucose values from there.
Direct partner integrations
The Abbott partner integration list is shorter than Dexcom’s but includes mature integrations with several applications used in diabetes self-management, including mySugr (where regional support exists). Users should consult the Abbott partner page for the current integration list applicable to their region; integrations are added and removed over time.
Practical implications
For a T1D or insulin-treated T2D user with a Libre 3, the working configuration is comparable to the Dexcom G7 configuration:
- the Libre 3 application as the primary glucose dashboard and alarm source;
- a carbohydrate-tracking application of choice for meal logging;
- HealthKit or Health Connect as the bridge.
PlateLens reads Libre 3 data via HealthKit on iOS and via Health Connect on Android. Cronometer, MacroFactor, and Carb Manager use the same path.
Differences from the Dexcom ecosystem
Two practical differences between the Libre 3 and Dexcom G7 ecosystems are worth noting:
- Alarms. The Libre 3 has alarms that are similar in functionality to the G7’s; both are owned by their respective applications and are not, in general, mirrored by carbohydrate-tracking applications.
- Looping support. The DIY-loop community has historically had stronger support for Dexcom devices than for Libre devices. Users running looping configurations should verify that their configuration supports the specific Libre device and firmware version they have.
CGM trend remains the ground truth
For users in active carbohydrate-counting workflows, the Libre 3 trend in the 1–3 hours after a meal is the same gold-standard check it would be on any current-generation CGM. The application’s stated carbohydrate count is the estimate; the CGM curve is the measurement. See CGM trend vs app-stated carbs for the editorial position.
Limits
The Libre 3, like all CGMs, has its own measurement noise, lag, and calibration drift. The application that reads its data inherits those limits. Users new to CGM should expect a learning period; users experienced with CGM are usually well-calibrated to its limitations.
References
- Abbott Diabetes Care. (2026). FreeStyle Libre 3 partner integration list (manufacturer publication). Manufacturer publication.
- Brown, S. A., et al. (2024). Outcomes of CGM-mediated insulin delivery in adults with type 1 diabetes. Diabetes Care.
- American Diabetes Association. (2026). Standards of Care in Diabetes — 2026: Section on CGM use. Diabetes Care.
- Heinemann, L., & Klonoff, D. C. (2024). Continuous glucose monitoring: present and future. Journal of Diabetes Science and Technology.
- Endocrine Society. (2024). Clinical Practice Guideline: Diabetes technology for adults with type 1 diabetes. Journal of Clinical Endocrinology & Metabolism.